A Phase 1 Crossover Trial Evaluating the Pharmacokinetics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Tenofovir (Primary) ; Tenofovir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors CONRAD
- 22 Jul 2015 Results presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
- 16 Apr 2015 Status changed from not yet recruiting to completed, according to to ClinicalTrials.gov record.
- 26 Jan 2013 New trial record